Buy Blueprint Medicines Stock | BPMC Stock Price & Latest News | Public.com

Blueprint Medicines

$0.00 (0.00%)Today

About BPMC

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alex...Read more

Community

People who own or watch this stock

News

News image
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
0
0

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1.3

Price Targets

What analysts think this stock will be worth

$78.90
current
$86.40
average

Events

List of events that could affect this stock.

06May

Earnings data Q1 2020

30Jul

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.72
-1.43
-2.15
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$2.14

Actual EPS
Q3 2020

Stats

Market Cap$4,27B
Volume12,4k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$102.98
1 Year Low$43.29
Open$78.48
High$79.86
Low$78.23

Buy any stock with any amount of money.

Download the App
Download the app